Just thinking  outside the box , with the proper BP deal after the FDA letter.  The tax loss opportunity that a BP would obtain via eventual partnership/ buyout I believe is higher than RVX current market cap, take the value the IP, $200 million upfront is a joke to any BP to have the opportunity for a Blockbuster with BETONMACE2 , I am assuming that once RVX receives the FDA letter for the new trial it will be a countdown to a deal , could be weeks after or months but DM definitively says no cheap financing so I will take his word on that ,  GLTA